Phase Ib/II Study of PLX 3397 and Eribulin in Patients With Metastatic Breast Cancer
This study is currently recruiting participants.
Verified November 2012 by University of California, San Francisco
Sponsor:
Hope Rugo, MD
Collaborators:
Susan G. Komen Breast Cancer Foundation
Plexxikon
Eisai Inc.
Information provided by (Responsible Party):
Hope Rugo, MD, University of California, San Francisco
ClinicalTrials.gov Identifier:
NCT01596751
First received: May 7, 2012
Last updated: November 14, 2012
Last verified: November 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study is currently recruiting participants. |
|---|---|
| Estimated Study Completion Date: | January 2016 |
| Estimated Primary Completion Date: | January 2015 (Final data collection date for primary outcome measure) |